Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients
Short-term Effect of the Intake of Moderately High-protein, Low-glycemic Load Products on Anthropometrical, Glucose Metabolism and Lipid Metabolism Biomarkers, in Type-2 Diabetes Patients
1 other identifier
interventional
17
1 country
1
Brief Summary
The main objective of this study is to evaluate the effects on anthropometric, glucose metabolism and lipid profile biomarkers of exchanging with high-protein, low-glycemic index products (40-30-30) the habitual breakfast, mid-morning and afternoon snacks on type-2 diabetes patients following a chronologically scheduled pattern.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 20, 2010
CompletedFirst Posted
Study publicly available on registry
December 21, 2010
CompletedSeptember 10, 2012
September 1, 2012
10 months
December 20, 2010
September 7, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Total Body weight
Total body weight will be measured at the beginning of the study (week 0), at week 4 (before starting the intervention with 40-30-30 products) and week 8 (end of the study).
weeks 0, 4 and 8
Fat Mass
Fat Mass will be measured at the beginning of the study (week 0), at week 4 (before starting the intervention with 40-30-30 products) and week 8 (end of the study).
weeks 0, 4 and 8
Fat-free mass
Fat-free mass will be measured at the beginning of the study (week 0), at week 4 (before starting the intervention with 40-30-30 products) and week 8 (end of the study).
weeks 0, 4 and 8
Secondary Outcomes (15)
Hip circumference
weeks 0, 4 and 8
Waist circumference
weeks 0, 4 and 8
Basal glucose concentration
weeks 0, 4 and 8
Basal Insulin Concentration
weeks 0, 4 and 8
HOMA-IR index
weeks 0, 4 and 8
- +10 more secondary outcomes
Interventions
Short-term analysis of the effects of the substitution of the habitual breakfast, mid-morning and afternoon snack of type-2 diabetes patients by 40-30-30 products. Longitudinal 2-period study
Eligibility Criteria
You may qualify if:
- Clinically diagnosed of type-2 Diabetes
- Under dietary treatment or with Metformin
- Body Mass Index (BMI) Between 22 and 35 kg/m2
You may not qualify if:
- BMI under 22 or over 35 kg/m2
- To follow a pharmacological treatment with other drugs but metformin
- To be already insulin-dependent
- To have other concomitant pharmacological treatments for weight loss, hormonal substitutive therapy, altered thyroid function, etc. without an stable dosage (at least three months prior the beginning of the study).
- To suffer from complications due to type 2 diabetes (microangiopathy, polyneuropathy, cardiopathy, hepatic and renal impairments, etc)
- To have a recent (less than 3 months before the beginning of the study) uncontrolled diagnostic of hypercholesterolemia and/or hypertriglyceridemia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinica Universidad de Navarra, Universidad de Navarralead
- Rovi Pharmaceuticals Laboratoriescollaborator
- Equipe Enervitcollaborator
Study Sites (1)
Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra
Pamplona, Navarre, 31008, Spain
Related Publications (1)
Navas-Carretero S, Abete I, Zulet MA, Martinez JA. Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study. Nutr J. 2011 Jul 14;10:74. doi: 10.1186/1475-2891-10-74.
PMID: 21756320RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alfredo Martinez, PhD
University of Navarra
- STUDY CHAIR
Santiago Navas-Carretero, PhD
University of Navarra
- STUDY CHAIR
Itziar Abete, PhD
University of Navarra
- STUDY CHAIR
M. Angeles Zulet, PhD
University of Navarra
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Main investigator
Study Record Dates
First Submitted
December 20, 2010
First Posted
December 21, 2010
Study Start
September 1, 2009
Primary Completion
July 1, 2010
Study Completion
September 1, 2010
Last Updated
September 10, 2012
Record last verified: 2012-09